-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ESP-01 in Endometrial Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ESP-01 in Endometrial Cancer Drug Details: ESP-01 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BEBT-260 in Pancreatic Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BEBT-260 in Pancreatic Cancer Drug Details: BEBT-260 is under development for the treatment of solid...
-
Company Profile
Chinook Therapeutics Inc – Company Profile
Chinook Therapeutics, Inc (Chinook)., formerly Aduro BioTech Inc is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. It's pipeline products include atrasentan, Bion- 1301 for the treatment of IgA Nephropathy, CHK-336 for idiopathic hyperoxaluria, research and discovery programs for the treatment of rare, severe chronic kidney diseases among others. The company develops product candidates using proprietary technology platforms such as live, attenuated, double-deleted listeria, sting pathway activators and B-select monoclonal antibodies to create...
Add to Basket -
Company Profile
Countrywide Ltd – Company Profile
insurance products and financial products. It offers panel management, property purchasing, and selling, residential valuations and surveys, mortgage- and brokerage, asset management, in-house maintenance, property management, and land development and management services. Countrywide also involves selling residential, commercial, and agricultural properties and land by public auction across the UK. Countrywide offers products and services under various brands including Abbotts, Accord Lets, APW Lettings, Ashby Lowery, Blundells, Chappell & Matthews, and CHK Mountford. Countrywide is headquartered in Milton Keynes, England, the...
Add to Basket -
Product Insights
Net Present Value Model: CHK-336
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model CHK-336 Drug Details CHK-336 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CHK-336
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry CHK-336 Drug Details CHK-336 is under development for the treatment of primary hyperoxaluria, secondary...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – BEBT-260
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry BEBT-260 Drug Details BEBT-260 is under development for the treatment of solid tumors including...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ESP-01
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ESP-01 Drug Details ESP-01 is under development for the treatment of solid tumours including...